Arshad R, Farooq S, Iqbal N, Ali S S
Nuclear Institute for Agriculture and Biology (NIAB), Faisalabad, Pakistan.
Lett Appl Microbiol. 2006 Feb;42(2):94-101. doi: 10.1111/j.1472-765X.2005.01819.x.
The present work aimed to improve the production of penicillin G acylase (PGA) and reduce the beta-lactamase activity through acridine orange (AO) induced mutation in Escherichia coli.
Three wild E. coli strains BDCS-N-FMu10, BDCS-N-S21 and BDCS-N-W50, producing both the enzymes PGA and beta-lactamase were treated by AO. Minimum inhibitory concentration of AO was 10 microg ml(-1) and it was noted that bacterial growth was gradually suppressed by increasing the concentration of AO from 10 to 100 microg ml(-1). The highest concentration that gave permissible growth rate was 50 microg ml(-1). The isolated survivals were screened on the bases of PGA and beta-lactamase activities. Among the retained mutants, the occurrence of beta-lactamase deficient ones (91%) was significantly higher than penicillin acylase deficient ones (27%).
In seven of the mutants, PGA activity was enhanced with considerable decrease in beta-lactamase activity. One of the mutant strains (BDCS-N-M36) exhibited very negligible expression of beta-lactamase activity and twofold increase in PGA activity [12.7 mg 6-amino-penicillanic acid (6-APA) h(-1) mg(-1) wet cells] compared with that in the wild-type strain (6.3 mg 6-APA h(-1) mg(-1) wet cells).
The treatment of E. coli cells with AO resulted in mutants with enhanced production of PGA and inactivation of beta-lactamase. These mutants could be used for industrial production of PGA.
本研究旨在通过吖啶橙(AO)诱导大肠杆菌突变,提高青霉素G酰化酶(PGA)的产量并降低β-内酰胺酶活性。
用AO处理三株野生型大肠杆菌BDCS-N-FMu10、BDCS-N-S21和BDCS-N-W50,这三株菌均能产生PGA和β-内酰胺酶。AO的最低抑菌浓度为10μg/ml,并且发现随着AO浓度从10μg/ml增加到100μg/ml,细菌生长逐渐受到抑制。能使细菌生长速率达到许可范围的最高浓度为50μg/ml。根据PGA和β-内酰胺酶活性对分离得到的存活菌株进行筛选。在保留的突变体中,β-内酰胺酶缺陷型(91%)的出现率显著高于青霉素酰化酶缺陷型(27%)。
在七个突变体中,PGA活性增强,同时β-内酰胺酶活性显著降低。其中一个突变菌株(BDCS-N-M36)的β-内酰胺酶活性表达极低,与野生型菌株(6.3mg 6-氨基青霉烷酸(6-APA)/h·mg-1湿细胞)相比,PGA活性提高了两倍(12.7mg 6-APA/h·mg-1湿细胞)。
用AO处理大肠杆菌细胞产生了PGA产量提高且β-内酰胺酶失活的突变体。这些突变体可用于PGA的工业生产。